Insider trade

Quest Diagnostics (DGX): Officer reported a transaction in 49 shares

Patrick Plewman, Officer at Quest Diagnostics, reported a transaction of 49 shares.

49
Shares · @ $194.70
Traded
Apr 20, 2026
Filed
Apr 24, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 10, 2025CongressDisclosed sale of DGX — reported range $15,001 - $50,000
  2. Oct 28, 2025Federal contract · $2.7M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $2.75M obligated to date
  3. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  4. Feb 19, 2026Insider · 3 peopleInsiders: 3 sales (~$717K)
  5. Mar 2, 2026InsiderCEO sold ~$2.13M of DGX shares in the open market
  6. Mar 3, 2026Insider · 3 peopleInsiders: 3 sales (~$326K)
  7. Mar 4, 2026InsiderOfficer sold ~$538K of DGX shares in the open market
  8. Mar 5, 2026Insider · 3 peopleInsiders: 3 sales (~$2.5M)
  9. Mar 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 9, 2026, the Board of Directors (the “Board”) of Quest Diagnostics Incorporated (the “Company”), after considering the recommendation of the Board's Governance Committee, elected Timothy Wentworth, former chief executive officer of Walgreens Boots Alliance, as a director.”
  10. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  11. Mar 27, 2026CongressDisclosed purchase of DGX — reported range $1,001 - $15,000
  12. Mar 30, 2026CongressDisclosed purchase of DGX — reported range $1,001 - $15,000
  13. Apr 1, 2026Federal contract · $3.1M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $3.12M obligated to date
  14. Apr 2, 2026Federal contract · $2.7M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $2.71M obligated to date

What came next

  1. Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
  2. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.5%
  3. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  4. May 1, 2026Federal contract · $2.6M obligatedDepartment of Veterans Affairs awarded Quest Diagnostics: $2.6M obligated to date
  5. May 6, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  6. Jun 1, 2026InsiderCEO sold ~$1.94M of DGX shares in the open market
  7. Jun 4, 2026Insider · Their largest sale since 2024Officer sold ~$1.63M of DGX shares in the open market
  8. Jul 23, 2026Company filing · Form 8-K · ResultsReported its results
  9. Jul 28, 2026InsiderOfficer sold ~$376K of DGX shares in the open market
  10. Aug 14, 20265% stakeT. Rowe Price Associates, Inc. reported a passive stake (13G) of 4.9%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Quest Diagnostics

For Quest Diagnostics, OQRO holds 20 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DGX page.

Other recent filings by Patrick Plewman, SVP for Diagnostic Services

The full history of Patrick Plewman, SVP for Diagnostic Services is on the profile page.

How this filing works

Explore the data

Common questions

Which Quest Diagnostics (DGX) insider traded, and how much?

Patrick Plewman, Officer at Quest Diagnostics, reported a transaction of 49 shares. At $194.70.

When did it happen, and when was it made public?

Traded: Apr 20, 2026. Filed: Apr 24, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Quest Diagnostics recently?

For Quest Diagnostics, OQRO holds 20 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the DGX page.

Does this mean DGX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Quest Diagnostics

Everything OQRO holds on this company is on its DGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data